Cargando…

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis

BACKGROUND: Our prior Systemic Treatment Options for Cancer of the Prostate systematic reviews showed improved survival for men with metastatic hormone-naive prostate cancer when abiraterone acetate plus prednisolone/prednisone (AAP) or docetaxel (Doc), but not zoledronic acid (ZA), were added to an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vale, C L, Fisher, D J, White, I R, Carpenter, J R, Burdett, S, Clarke, N W, Fizazi, K, Gravis, G, James, N D, Mason, M D, Parmar, M K B, Rydzewska, L H, Sweeney, C J, Spears, M R, Sydes, M R, Tierney, J F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961275/ https://www.ncbi.nlm.nih.gov/pubmed/29788164 http://dx.doi.org/10.1093/annonc/mdy071

Ejemplares similares

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
por: Burdett, Sarah, et al.
Publicado: (2019)

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
por: Vale, Claire L, et al.
Publicado: (2016)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
por: Rydzewska, Larysa H.M., et al.
Publicado: (2017)

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience
por: Tierney, Jayne F, et al.
Publicado: (2015)

A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
por: Tierney, Jayne F., et al.
Publicado: (2021)

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials()
por: Vale, Claire L., et al.
Publicado: (2015)

Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change
por: Fisher, David J., et al.
Publicado: (2022)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Practical methods for incorporating summary time-to-event data into meta-analysis
por: Tierney, Jayne F, et al.
Publicado: (2007)

Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study
por: Tierney, Jayne F., et al.
Publicado: (2020)

Assessing and improving the reliability of meta-analyses of hazard ratios derived from published time-to-event data
por: Tierney, Jayne, et al.
Publicado: (2013)

A framework for identifying treatment‐covariate interactions in individual participant data network meta‐analysis
por: Freeman, S. C., et al.
Publicado: (2018)

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
por: Mason, Malcolm D., et al.
Publicado: (2017)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017)

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
por: South, Annabelle, et al.
Publicado: (2016)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
por: Dearnaley, David P, et al.
Publicado: (2009)

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses
por: Xie, Wanling, et al.
Publicado: (2019)

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.
por: Tierney, J. F., et al.
Publicado: (1995)

Data provenance and integrity of health-care systems data for clinical trials
por: Murray, Macey L, et al.
Publicado: (2022)

How individual participant data meta-analyses have influenced trial design, conduct, and analysis
por: Tierney, Jayne F., et al.
Publicado: (2015)

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
por: Sydes, M R, et al.
Publicado: (2018)

No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial
por: Nur, U, et al.
Publicado: (2008)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

Differential CpG DNA methylation in peripheral naïve CD4(+) T-cells in early rheumatoid arthritis patients
por: Pitaksalee, R., et al.
Publicado: (2020)

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data
por: Navani, Neal, et al.
Publicado: (2019)

How do you design randomised trials for smaller populations? A framework
por: Parmar, Mahesh K. B., et al.
Publicado: (2016)

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
por: del Campo, J M, et al.
Publicado: (2011)

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
por: Sinha, S., et al.
Publicado: (2012)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Effect of lactation stage and concurrent pregnancy on milk composition in the bottlenose dolphin
por: West, K L, et al.
Publicado: (2007)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Elastase levels and activity are increased in dystrophic muscle and impair myoblast cell survival, proliferation and differentiation
por: Arecco, N., et al.
Publicado: (2016)

Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV‐Naïve Recipients of Infected Donor Allograft Hearts
por: Streblow, D. N., et al.
Publicado: (2015)

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma
por: Thamm, D.H., et al.
Publicado: (2017)

Parenteral oestrogen in the treatment of prostate cancer: a systematic review
por: Norman, G, et al.
Publicado: (2008)

Sharing individual participant data: through a systematic reviewer lens
por: Rydzewska, Larysa H. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlpg8e9viebkhj659fok4uv5b2